BML Investment Partners Amends Enliven Therapeutics Stake

TL;DR

**BML Investment Partners updated their Enliven Therapeutics stake, signaling a potential shift in their investment thesis.**

AI Summary

BML Investment Partners, L.P. has filed an Amendment No. 3 to its Schedule 13G, indicating a change in its beneficial ownership of Enliven Therapeutics, Inc. common stock as of December 31, 2023. This filing, made on February 7, 2024, updates their previous disclosures regarding their stake in the pharmaceutical preparations company. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or strategy regarding the stock.

Why It Matters

Changes in major institutional holdings can influence stock price and investor sentiment, as large investors often have deep insights into a company's prospects.

Risk Assessment

Risk Level: low — This filing is a routine update on institutional ownership and does not inherently indicate a high level of risk.

Analyst Insight

Investors should monitor subsequent filings from BML Investment Partners, L.P. and other institutional investors to understand the full scope of changes in ownership and potential implications for Enliven Therapeutics, Inc.'s stock.

Key Players & Entities

• BML Investment Partners, L.P. (company) — the reporting person filing the SC 13G/A
• Enliven Therapeutics, Inc. (company) — the subject company whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• February 7, 2024 (date) — the filing date of the SC 13G/A
• Delaware (company) — state of incorporation for BML Investment Partners, L.P.

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• elvn13g020724.htm (SC 13G/A) — 74KB
• 0001616824-24-000030.txt ( ) — 76KB

(a)

Item 1(a). Name of Issuer: Enliven Therapeutics, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 6200 Lookout Road, Boulder, CO 80301

(a)

Item 2(a). Name of Person Filing: BML Investment Partners, L.P.

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E Cedar - Suite 2 Zionsville, IN 46077

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share

(e)

Item 2(e). CUSIP Number: 29337E102 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 50000 (b) Percent of class: 0.1 (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 50000 (iii) Sole power to dispose or to direct the disposition of:0 (iv) Shared power to dispose or to direct the disposition of: 50000 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securitie

View Full Filing

View this SC 13G/A filing on SEC EDGAR